Skip to main content
Bernadette Murphy, MD, Pediatrics, Fairfax, VA, Inova Fair Oaks Hospital

BernadetteM.MurphyMD

Pediatrics Fairfax, VA

Assistant Professor, Pediatrics, Georgetown University School of Medicine

Dr. Murphy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Murphy's full profile

Already have an account?

Education & Training

  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Pediatrics, 1991 - 1994
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1990

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1993 - 2026
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014
  • Fellow (FAAP) American Academy of Pediatrics

Press Mentions

  • The Global Summit on the Efficacy and Effectiveness of Spinal Manipulative Therapy for the Prevention and Treatment of Non-Musculoskeletal Disorders: A Systematic Review of the Literature
    The Global Summit on the Efficacy and Effectiveness of Spinal Manipulative Therapy for the Prevention and Treatment of Non-Musculoskeletal Disorders: A Systematic Review of the LiteratureFebruary 17th, 2021
  • The Global Summit on the Efficacy and Effectiveness of Spinal Manipulative Therapy for the Prevention and Treatment of Non-Musculoskeletal Disorders: A Systematic Review of the Literature
    The Global Summit on the Efficacy and Effectiveness of Spinal Manipulative Therapy for the Prevention and Treatment of Non-Musculoskeletal Disorders: A Systematic Review of the LiteratureFebruary 17th, 2021
  • Characterization and Management of ERK Inhibitor Associated Dermatologic Adverse Events: Analysis from a Nonrandomized Trial of Ulixertinib for Advanced Cancers
    Characterization and Management of ERK Inhibitor Associated Dermatologic Adverse Events: Analysis from a Nonrandomized Trial of Ulixertinib for Advanced CancersJanuary 3rd, 2021

Professional Memberships

Hospital Affiliations